Company Filing History:
3 out of 24 
2 out of 290 
1 out of 228 
Years Active: 2015-2023
Title: The Innovative Mind of Torben Gjetting
Introduction: Torben Gjetting, an inventive spirit based in Jyllinge, Denmark, has made notable contributions to the field of biotechnology through his numerous patented inventions. With a total of seven patents to his name, Gjetting is recognized for his cutting-edge work focusing on antibodies and their applications in treating serious medical conditions such as cancer.
Latest Patents: Among his latest innovations, Gjetting has developed the following impressive patents:
1. **Anti-LAG-3 Antibodies and Compositions** - This invention pertains to anti-LAG-3 antibodies and explores methods for their use in treating diseases and conditions that benefit from modulating LAG-3 activity, including cancer.
2. **Anti-AXL Antibodies and Compositions** - This patent covers anti-AXL antibodies and describes methods for utilizing them in treating diseases and conditions associated with AXL activity, particularly in cancer cases.
Career Highlights: Throughout his career, Torben Gjetting has collaborated with renowned companies such as Symphogen A/S and Les Laboratoires Servier. His work has significantly advanced the understanding and treatment of diseases through biopharmaceutical innovations.
Collaborations: Gjetting has worked alongside talented individuals in the field, including coworkers Michael Monrad Grandal and Gunther Roland Galler. These collaborations have fostered a rich environment for innovation and development in biomedicine.
Conclusion: Torben Gjetting's contributions to biotechnology through his patents underscore his role as a prominent inventor in the field. His work on anti-LAG-3 and anti-AXL antibodies demonstrates the potential of his inventions to improve therapeutic strategies for cancer treatment and other serious conditions. As he continues to innovate, Gjetting remains a key figure to watch in the landscape of biotechnology and medical research.